Advanced Enzyme Technologies Limited — Important, 08-02-2025: Financial Result Updates

**Consolidated Financial Summary:**

Advanced Enzyme Technologies has reported consolidated revenue from operations of ₹1,609.35 crore for the quarter ended December 31, 2024, marking a year-over-year increase of 9.73%. This growth can be attributed to rising demand across key markets and effective expansion strategies that improved product accessibility.

Net profit for the quarter came in at ₹333.93 crore, reflecting a year-over-year decline of 20.56%. The Earnings Per Share (EPS) stood at ₹3.36, down from ₹4.24 in the previous year. This decrease in profitability is influenced by higher operational costs, specifically in materials and workforce expenses, which saw a combined rise of approximately 15%.

Total operational cost escalated to ₹1,277.84 crore, which is 11.88% higher compared to the same period last year. Significant contributors to this increase were the costs associated with expansion efforts and higher employee benefits. The company's proactive cost management measures are critical to regaining profitability.

The balance sheet remains robust, with total assets standing at ₹6,238.68 crore and a healthy cash flow position supporting ongoing operational expenses and investments. Future strategic focuses include enhancing operational efficiency and pursuing growth in underpenetrated markets.

Given the current financial performance and operational challenges, a cautious approach is advised: consider holding until clearer signs of recovery in profitability and cost control efforts materialize.